Boston Scientific (BSX) Other Non-Current Assets (2009 - 2026)
Boston Scientific (BSX) reported Other Non-Current Assets of $2.1 billion for Q1 2026, down 94.88% on a YoY basis from $40.1 billion in Q1 2025, and down 95.3% sequentially from $43.7 billion in Q4 2025.
Boston Scientific (BSX) Other Non-Current Assets (2009 - 2026) Analysis & Trends
Boston Scientific (BSX) has 18 years of Other Non-Current Assets data on file, last reported at $2.1 billion in Q1 2026.
- For the quarter ending Q1 2026, Other Non-Current Assets fell 94.88% year-over-year to $2.1 billion; the trailing twelve-month figure through Mar 2026 stood at $2.1 billion (down 94.88% YoY), and the FY2025 full-year result was $43.7 billion, up 10.86% from the prior year.
- Other Non-Current Assets declined to $2.1 billion in Q1 2026, from $43.7 billion in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $43.7 billion in Q4 2025 to a low of $1.4 billion in Q1 2022.
- A 5-year average of $15.3 billion and a median of $1.6 billion in 2023 frame the typical range for Other Non-Current Assets.
- Across the five-year window, Other Non-Current Assets surged 2579.5% in 2025 and sank 94.88% in 2026, its largest moves.
- Tracing BSX's Other Non-Current Assets over 5 years: stood at $1.5 billion in 2022, then jumped by 2242.4% to $35.1 billion in 2023, then advanced by 12.12% to $39.4 billion in 2024, then advanced by 10.86% to $43.7 billion in 2025, then sank by 95.3% to $2.1 billion in 2026.
- Business Quant data shows BSX's Other Non-Current Assets at $2.1 billion in Q1 2026, $43.7 billion in Q4 2025, and $42.7 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 3.17 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 4.15 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 2.05 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 738.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 285.90 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 828.89 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 2.25 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 164.00 Mn |
| 10 | Steris | 20.59 Bn | 20.16 Bn | 697.10 Mn | 211.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.05 Bn |
| Dec 31, 2025 | 43.67 Bn |
| Sep 30, 2025 | 42.71 Bn |
| Jun 30, 2025 | 41.56 Bn |
| Mar 31, 2025 | 40.14 Bn |
| Dec 31, 2024 | 39.40 Bn |
| Sep 30, 2024 | 1.64 Bn |
| Jun 30, 2024 | 1.55 Bn |
| Mar 31, 2024 | 1.60 Bn |
| Dec 31, 2023 | 35.14 Bn |
| Sep 30, 2023 | 1.61 Bn |
| Jun 30, 2023 | 1.60 Bn |
| Mar 31, 2023 | 1.48 Bn |
| Dec 31, 2022 | 1.50 Bn |
| Sep 30, 2022 | 1.60 Bn |
| Jun 30, 2022 | 1.57 Bn |
| Mar 31, 2022 | 1.38 Bn |
| Dec 31, 2021 | 1.41 Bn |
| Sep 30, 2021 | 1.44 Bn |
| Jun 30, 2021 | 1.63 Bn |